HealthEquity, Inc. (NASDAQ:HQY) Director Sells $837,870.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the transaction, the director now directly owns 66,469 shares in the company, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

HealthEquity Price Performance

NASDAQ HQY traded up $1.97 during trading on Wednesday, reaching $97.36. The company’s stock had a trading volume of 845,139 shares, compared to its average volume of 634,217. The firm has a fifty day moving average of $93.11 and a 200 day moving average of $83.90. HealthEquity, Inc. has a one year low of $62.10 and a one year high of $105.82. The stock has a market capitalization of $8.50 billion, a PE ratio of 78.54, a P/E/G ratio of 1.57 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. International Assets Investment Management LLC purchased a new stake in HealthEquity during the second quarter valued at about $35,000. Paladin Wealth LLC bought a new position in shares of HealthEquity during the 3rd quarter valued at about $39,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of HealthEquity during the 2nd quarter valued at about $73,000. GAMMA Investing LLC lifted its position in HealthEquity by 57.8% in the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after buying an additional 344 shares during the last quarter. Finally, Quarry LP boosted its stake in HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after buying an additional 1,089 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of research analyst reports. Bank of America boosted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Barrington Research increased their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday, December 2nd. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday. The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. Finally, BTIG Research boosted their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus target price of $110.71.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.